Sunday , December 17 2017
Home / Letter From The Editor / July 26, 2016

July 26, 2016

dave

There are various hormones, neurotransmitters, nucleotides, and fatty acids in the pancreas that affect insulin production and secretion. Sorting all these factors out, and how we might possibly affect glucose control by mimicking  some of these compounds, has opened up new avenues of treatment. GLP-1 agonists are just one example. This week in our Clinical Text we continue our explanation of how these compounds work, and how we will continue to make progress towards better control.

 

Dave Joffe
Editor-in-chief